ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Colorectal cancer is highly preventable when detected early, yet approximately 4 in 10 eligible adults are not up to date with recommended screenings. While at-home tests offer convenience, the ...
Labcorp has announced the availability of ColoSense, its ribonucleic acid (RNA)-based at-home screening test for colorectal cancer that has been approved by the US Food and Drug Administration (FDA).
Like Cologuard, which the FDA approved in 2014, ColoSense is a stool-based screening test for colorectal cancer. Cologuard detects abnormal DNA and blood, while ColoSense tests for RNA markers and ...
ColoSense uses RNA-based methods to detect biomarkers linked to colorectal cancer and advanced adenomas, which are precancerous. Credit: Labcorp / PRNewswire. Labcorp has announced the availability of ...
Send identical stool to seven different gut microbiome test companies and you will get seven wildly different answers. That is essentially what a new study did, and the results should give anyone who ...
Infections caused by a microscopic parasite called Cyclospora have been reported in at least 18 states, with numbers continuing to climb. Contaminated fresh produce is typically the source of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results